Yunping Dai

Title: The Innovations of Yunping Dai

Introduction

Yunping Dai is a prominent inventor based in Beijing, China. He is known for his significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has the potential to revolutionize therapeutic approaches in cancer treatment.

Latest Patents

Yunping Dai holds a patent for an afucosylated monoclonal antibody. This innovative antibody is a human IgG antibody characterized by an afucosylated sugar chain structure at a heavy-chain sugar chain binding site. The patent outlines the application of this monoclonal antibody in the preparation of antineoplastic drugs. Compared to fucosylated monoclonal antibodies, the afucosylated variant demonstrates higher biological activity both in vitro and in vivo. This advancement can lead to the development of more effective therapeutic monoclonal antibody drugs.

Career Highlights

Throughout his career, Yunping Dai has worked with notable companies such as Beijing Gefucure Biotechnology Limited Company and Wuxi Kingenew Biotechnology Limited Company. His experience in these organizations has contributed to his expertise in biotechnology and patent development.

Collaborations

Yunping Dai has collaborated with several professionals in his field, including Bo Tang and Ran Zhang. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in biotechnology.

Conclusion

Yunping Dai's contributions to the field of biotechnology, particularly through his patent for an afucosylated monoclonal antibody, highlight his role as an influential inventor. His work promises to advance therapeutic options for cancer treatment and showcases the importance of innovation in medicine.